AstraZeneca introduces AZhelps, an innovative savings and support program to help patients with their medicines

AstraZeneca today announced it has expanded  its patient support offerings to include AZhelps, a comprehensive and unique program that helps patients manage information across all their medications, access savings offers for their AstraZeneca medicines, and easily access healthcare support through their mobile devices and on social media channels.

Lori Tierney, Vice President, Commercial Operations, at AstraZeneca said: “AstraZeneca is committed to providing affordable medicines and programs that help patients get the support they need. AZhelps is a new way for people to help take charge of their health—absolutely free. It allows patients to easily access information about their medications, better manage their wellness, and access important savings information, all from their smartphone as soon as they need information.”

The centerpiece of the program is the AZhelps mobile app, which gives eligible patients prescription savings, personalized healthcare information, healthy lifestyle advice, and the ability to connect with the AstraZeneca Information Center via phone or Twitter—all right from their smartphone in the moments when they need it most. Created with today’s mobile lifestyle in mind, the service helps patients:


  • The AZhelps mobile Savings Card helps eligible patients lower out-of-pocket costs on multiple medications made by AstraZeneca
  • Once registered, patients can access their mobile card through the AZhelps app or add it to Apple Wallet or Android Pay for easy access at the pharmacy
  • The AZhelps mobile Savings Card is also available for download by registering for it on each AstraZeneca brand’s mobile site
  • Eligible patients will also receive mobile mail-order refill reimbursement, and through the app’s Savings History feature, patients are able to see their savings while using the program


  • Patients can track all of their prescriptions and set medication and refill reminders to align with their personal treatment schedules
  • A Tracking History feature shows patients how long they have been following their treatment plan
  • Because their progress and treatment history is stored in one place and instantly accessible via their smartphone, patients are able to share the information with their doctor at their next visit
  • A mobile refill functionality allows patients to order refills of their participating AstraZeneca prescriptions from their pharmacy straight from their phone.   The app also lets them know when their refills are running low  


  • AZhelps provides health and wellness support, information, and advice, helping patients find answers to questions about their medications and lifestyle
  • Health-related content is available within the app and offers tips and articles from trusted content providers centered on each patient’s individual needs
  • Patients can access important information about their AstraZeneca medications, and tap-to-call the AstraZeneca Information Center for support and answers to questions, right from their phone 

The AZhelps program also includes social channels, offering customer support and helpful health information on Twitter, Facebook, and Instagram. The social channels incorporate an array of content including how-to videos, GIFs, recipes, and lifestyle tips. The channels also serve as customer service support channels, with the AstraZeneca Information Center engaging and helping patients directly through social media. 

Consumers can engage with AZhelps on the following social channels:

The following brands are available on the AZhelps app:

  • CRESTOR® (rosuvastatin calcium)
  • SYMBICORT® (budesonide/formoterol fumarate dihydrate) 

Please read full Prescribing Information, including Boxed WARNING, and Medication Guide.

  • FARXIGA® (dapagliflozin)
  • SEROQUEL XR® (quetiapine fumarate)

Please read full Prescribing Information, including Boxed WARNINGS, and Medication Guide.

  • BRILINTA® (ticagrelor)

Please read full Prescribing Information, including Boxed WARNINGS, and Medication Guide.

  • BYDUREON® (exenatide extended-release) for injectable suspension

Please read full Prescribing Information, including Boxed WARNING, and Medication Guide.

  • BYETTA® (exenatide)
  • DALIRESP® (roflumilast)
  • KOMBIGLYZE® XR (saxagliptin and metformin HCI extended-release)

Please read full Prescribing Information, including Boxed WARNING, and Medication Guide.

  • NEXIUM® (esomeprazole magnesium)
  • ONGLYZA® (saxagliptin)
  • PULMICORT FLEXHALER® (budesonide inhalation powder)
  • TUDORZA® PRESSAIR® (aclidinium bromide inhalation powder)
  • XIGDUO® XR (dapagliflozin/metformin HCI extended-release)

Please read full Prescribing Information, including Boxed WARNING, and Medication Guide.

AZhelps is now available to download for free from the Apple App store and Google Play.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit or call 1-800-FDA-1088.

If you would like a printed copy of an AstraZeneca medication’s full Prescribing Information please call us at 1-800-236-9933.

AstraZeneca offers the AZ&MeTM Prescription Savings Program. To determine eligibility, patients can visit or call 1-800-AZandMe (292-6363).


About AstraZeneca
AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in three main therapy areas - respiratory, inflammation, autoimmune disease (RIA), cardiovascular and metabolic disease (CVMD) and oncology – as well as in infection and neuroscience. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information, please visit


Media Inquiries

Michele Meixell                        +1 302 885 2677

Abigail Bozarth                        +1 302 885 2677